-
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
27 Jan 2026 12:00 GMT
… approved treatments for MERTK-related retinitis pigmentosa. The Opus MERTK program … the population. MERTK-related retinitis pigmentosa affects approximately 60,000 patients … patients living with MERTK-related retinitis pigmentosa, this trial represents the …
-
This new tech can help visually-impaired sports fans experience the Super Bowl
04 Feb 2026 16:40 GMT
… North Carolina man wasdiagnosed with Retinitis Pigmentosa, or RP, at the age …
-
Why Some Retinitis Pigmentosa Cases Went Undiagnosed for Decades
09 Jan 2026 16:18 GMT
Retinitis pigmentosa (RP) is a genetic eye … -8 and RNU6-9) cause retinitis pigmentosa. These genes produce RNA molecules … and U6 snRNA genes cause retinitis pigmentosa. Nat Genet. 2026. doi: 10 …
-
GAP-43 Gene-Modified Stem Cells Combat Retinitis Pigmentosa
09 Jan 2026 07:53 GMT
… avenues for treatment beyond just retinitis pigmentosa.
The implications of this … beyond the immediate benefits for retinitis pigmentosa patients. By uncovering the … with enhanced therapeutic options for retinitis pigmentosa is becoming increasingly clear. …
-
Retinitis Pigmentosa Market Competition Analysis 2025: How Players Are Shaping Growth
18 Dec 2025 05:51 GMT
… the Market?
• Advancements in retinitis pigmentosa treatment to accelerate research, … February 2025) accelerates research into retinitis pigmentosa (RP), a progressive retinal … com/report/retinitis-pigmentosa-global-market-report
The Business …
-
Human-only RPGR isoform and Rho/ROCK1 inhibitor as approach for X-linked retinitis pigmentosa
12 Nov 2025 00:34 GMT
… turnover known to occur in retinitis pigmentosa.
BioWorld Science Ocular
-
<![CDATA[Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials]]>
10 Nov 2025 23:17 GMT
… optogenetic therapy for patients with retinitis pigmentosa and Stargardt disease at the … retinal diseases. In patients with retinitis pigmentosa, vision gains averaged about … optogenetic therapy in adults with retinitis pigmentosa and Stargardt disease, and …